z-logo
Premium
Acute podocyte injury enhances the susceptibility to blood pressure‐induced injury in rats with underlying ¾ renal mass reduction
Author(s) -
Polichnowski Aaron James,
Picken Maria M.,
Griffin Karen A.,
Bidani Anil K.
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.1110.20
Subject(s) - glomerulosclerosis , medicine , endocrinology , proteinuria , blood pressure , podocyte , renal function , kidney disease , kidney , urology
The mechanism by which acute podocyte loss promotes chronic kidney disease (CKD) progression remains poorly understood. We administered a single dose (75 mg/kg i.p.) of puromycin aminonucleoside (PAN, n=14) or saline (sham, n=12) to male Sprague‐Dawley rats 2 weeks after ¾ renal mass reduction via surgical excision. BP was measured continuously every 10 minutes via radiotelemetry (DSI) and 24 hour urine protein excretion was determined weekly for 4 weeks following PAN administration. Two weeks after renal mass reduction and prior to administration of PAN the average systolic BP (125±3 vs. 129±3 mmHg) and 24‐hour proteinuria (8±1 vs. 18±7 mg/day) were similar in the PAN and sham groups, respectively. By contrast, four weeks after PAN administration the average systolic BP (147±4 vs. 135±5 mmHg; p<0.05) and 24 hour proteinuria (255±16 vs 34+8 mg/day; p<0.05) were significantly increased in the PAN vs. sham rats; respectively. Consistent with these findings, glomerulosclerosis (GS, 68±6% vs. 8+3% per 100 glomeruli; p<0.05) and the slope of the relationship between the %GS and average systolic BP (y=1.1x‐87 vs. y=0.4x‐52 %GS/mmHg) was also greater in PAN vs. sham rats; respectively. These data indicate that podocyte loss in the presence of impaired preglomerular autoregulation results in enhanced glomerular susceptibility to hypertensive injury with even modest increases in BP.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here